A New Hope for Women Trapped by PMOS Polyendocrine metabolic ovarian syndrome (PMOS) often remains undiagnosed or misdiagnosed, leaving women like Charlotte Touzalin frustrated for years.
The condition's complex symptoms weight gain, abnormal periods, and unwanted facial hair can leave patients feeling trapped in a medical cycle of misdiagnosis.
Recent research on GLP 1 drugs offers a glimmer of hope for those affected by PMOS. Studies conducted by Dr.